Investor Presentation (Generex) - Mar 13, 2012 - AE 37 / Generex; Anticipated completion of P2 trial for breast cancer in 2012; Anticipated initiation of P3 trial for breast cancer in Q1 2012
Anticipated P2 trial completion • Anticipated P3 trial initiation • Oncology
|
|
AE 37
-- -- --
P2 Trial Complete in 2012
Initiate Phase III AE37 for breast cancer
-- -- --
|